The life sciences sector is at a crossroads as the FDA updates quality management standards. AI is now expected, and the FDA’s January 2025 draft guidance outlines its evaluation and implementation. Successful adoption depends on three key questions.
Safe and Sane: Understanding the FDA’s Risk-Based Approach to AI
Related Posts
Maximizing Precision: How to Care for and Integrate Your Handheld Gages
Experts advise that calibration schedules should be both flexible and systematic. Alongside calibration and inspection, simple practices such…
imc Test & Measurement ARGUSfit B-4 Measurement Module
imc Test & Measurement, a brand of Axiometrix Solutions, introduces the new and universally applicable imc ARGUSfit B-4…
Top 9 Insurance Industry Trends to Watch Out In 2023
Content 1. Top Nine Insurance Industry Trends To Watch Out for 1.1 Distributed infrastructure 1.2 Digital transformation 1.3…
